CClinicalTrials.gg
CompletedNCT05692375Updated Mar 31, 2023

Impact of the Save the Shame! Game on Advanced Life Support Knowledge

An interventional study of Invitation to play the game "Save the shame!" in Intensive Care, sponsored by Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.. Completed at 1 site in Portugal. Per ClinicalTrials.gov, last updated 2023-03-31.

Sponsored by Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Jun 2022, registered Jan 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Sex
All
01

Study summary

Gamification, listed by the European Resuscitation Council (ERC) as a learning process in its 2021 guidelines, is a new digital innovation tool that brings added value towards motivation that seems to reuse time in a creative way. The aim of this study is to evaluate the impact of the game "Save the shame!" on advanced life support (ALS) knowledge of nurses and physicians in intensive care medicine settings. This is a cross-sectional study following a mixed methodology. In its preliminary phase it follows a qualitative and exploratory methodology, with application of the E-Delphi technique for creation and validation of the "Save the shame! game and validation of the ALS knowledge test. The study subsequently follows the experimental methodology. The investigators expect to confirm the hypothesis that the game "Save the Shame!" has a positive impact on the skills training of health professionals in intensive care medicine settings in a Portuguese hospital center.

Read the detailed description

Study Design The investigators developed an experimental approach, where randomization in sample identification was ensured and where a control group was present, favoring a strongest level of contribution to the evidence. This is a cross-sectional study with quantitative data collection following a Randomized Controlled Trial (RCT) design.

In order to carry out the proposed experimental study, it was necessary to create two essential elements in this process: the "Save the Same!" game and the ALS knowledge assessment test, which constitutes a data collection instrument necessary to test the research hypotheses.

Arms, Groups, and Interventions The population was defined as nurses and physicians of the intensive care units of a Portuguese hospital center (N=275). The inclusion criteria were, to be a nurse or a physician, to provide care in a intensive care unit of the identified hospital center (cirurgical, cardiothoracic, coronary, medical or trauma). On the other hand, the exclusion criteria were, be any other health professional, providing care in settings other than intensive care settings, absence of informed consent, belonging to the invited group of experts, participation in the instrument design pre-test.

Participants were invited via institutional email and data was collected through the access of on-line platforms.

The experimental group was asked to use the game. Two weeks were defined as the time to use the game. The use of the game can be seen by the coded digital record on its digital platform. The control group neither used nor had access to the game. Afterwards both groups performed the ALS knowledge assessment test. It is a test with 20 multiple choice questions each scored as right (0.5 points) or wrong (0 points).

The sample was stratified in order to eliminate "professional group" variable. This was a protocol update at made at 10th of March

02

Conditions studied

  • Intensive Care

Keywords

  • healthcare
  • gamification
  • education
  • advanced life support
03

In context

Lead sponsor

Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. is the lead sponsor of 6 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • to be a nurse or a physician,
  • to provide care in a intensive care unit of the identified hospital center (cirurgical, cardiothoracic, coronary, medical or trauma)

Exclusion criteria

Exclusion Criteria:

  • be any other health professional
  • providing care in settings other than intensive care settings
  • absence of informed consent
  • belonging to the invited group of experts
  • participation in the instrument design pre-test
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
24 participants (actual)

Study arms

  • Experimental
    Experimental

    The experimental group will be inveted to use the game. Two weeks were defined as the time to use the game. The use of the game can be seen by the coded digital record on its digital platform .

    Other: Invitation to play the game "Save the shame!"

  • No intervention
    Control

    The control group neither used nor had access to the game.

Interventions

  • OtherInvitation to play the game "Save the shame!"

    The experimental group was asked to use the game. Two weeks were defined as the time to use the game. The use of the game can be seen by the coded digital record on its digital platform . The control group neither used nor had access to the game. Afterwards both groups performed the ALS knowledge assessment test. It is a test with 20 multiple choice questions each scored as right (0.5 points) or wrong (0 points).

06

What researchers measure

Primary outcomes

  1. The score at the advanced life support knowledge assessment test

    The minimun score at the scale is 0 and the maximum is 100, were 100 means the best result. It was applied through an online application, facilitating the participation of the guests and providing the automatic transcription of the results. The platform registration was carried out in a coded manner, thus ensuring the anonymity of the participants.

    Time frame: 3 weeks

07

Study locations

1 site
  • Chvng
    Vila Nova De Gaia, Portugal
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 31, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05692375
Lead sponsor
Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.
Collaborators
University of Minho
Responsible party
Sara Santos Ribeiro (Principle investigator, Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.) — Principal investigator
First posted
Jan 20, 2023
Start date
Jun 1, 2022
Primary completion
Aug 10, 2022
Completion
Oct 1, 2022
Last update
Mar 31, 2023

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion